益佰制药：控股股东部分股份质押及解除质押，占总股本2.65%

Core Viewpoint - The announcement from Yibai Pharmaceutical indicates that the controlling shareholder, Dou Qiling, has engaged in partial share pledges and releases, which are primarily aimed at debt repayment and do not pose a risk to the company's operations or control [1] Group 1: Share Pledge Details - Dou Qiling pledged 21 million shares to Guotai Junan Securities, representing 11.32% of her holdings and 2.65% of the total share capital, for debt repayment, starting from November 26, 2025, and maturing on November 26, 2026 [1] - On November 27, 2025, Dou Qiling will release 22.6683 million shares from pledge, which accounts for 12.22% of her holdings and 2.86% of the total share capital [1] - The total pledged shares by Dou Qiling and her concerted parties amount to 21 million shares, representing 11.31% of their combined holdings and 2.65% of the total share capital [1] Group 2: Risk Assessment - The company assesses that the risk associated with the pledged shares is manageable and will not affect its operations or control [1]